Identification of Side Chain Oxidized Sterols as Novel Liver X Receptor Agonists with Therapeutic Potential in the Treatment of Cardiovascular and Neurodegenerative Diseases.
Identification of Side Chain Oxidized Sterols as Novel Liver X Receptor Agonists with Therapeutic Potential in the Treatment of Cardiovascular and Neurodegenerative Diseases.
复制标题
鉴定侧链氧化甾醇为新的肝X受体激动剂,在治疗心血管和神经退行性疾病方面具有治疗潜力。
DOI:
10.3390/ijms24021290
复制
发表时间:
2023-01-09
影响因子:
5.6
通讯作者:
Mulder, Monique T.
中科院分区:
文献类型:
--
作者:
Zhan, Na;Wang, Boyang;Martens, Nikita;Liu, Yankai;Zhao, Shangge;Voortman, Gardi;Van Rooij, Jeroen;Leijten, Frank;Vanmierlo, Tim;Kuipers, Folkert;Jonker, Johan W.;Bloks, Vincent W.;Luetjohann, Dieter;Palumbo, Marcella;Zimetti, Francesca;Adorni, Maria Pia;Liu, Hongbing;Mulder, Monique T.
The nuclear receptors—liver X receptors (LXR α and β) are potential therapeutic targets in cardiovascular and neurodegenerative diseases because of their key role in the regulation of lipid homeostasis and inflammatory processes. Specific oxy(phyto)sterols differentially modulate the transcriptional activity of LXRs providing opportunities to develop compounds with improved therapeutic characteristics. We isolated oxyphytosterols from Sargassum fusiforme and synthesized sidechain oxidized sterol derivatives. Five 24-oxidized sterols demonstrated a high potency for LXRα/β activation in luciferase reporter assays and induction of LXR-target genes APOE, ABCA1 and ABCG1 involved in cellular cholesterol turnover in cultured cells: methyl 3β-hydroxychol-5-en-24-oate (S1), methyl (3β)-3-aldehydeoxychol-5-en-24-oate (S2), 24-ketocholesterol (S6), (3β,22E)-3-hydroxycholesta-5,22-dien-24-one (N10) and fucosterol-24,28 epoxide (N12). These compounds induced SREBF1 but not SREBP1c-mediated lipogenic genes such as SCD1, ACACA and FASN in HepG2 cells or astrocytoma cells. Moreover, S2 and S6 enhanced cholesterol efflux from HepG2 cells. All five oxysterols induced production of the endogenous LXR agonists 24(S)-hydroxycholesterol by upregulating the CYP46A1, encoding the enzyme converting cholesterol into 24(S)-hydroxycholesterol; S1 and S6 may also act via the upregulation of desmosterol production. Thus, we identified five novel LXR-activating 24-oxidized sterols with a potential for therapeutic applications in neurodegenerative and cardiovascular diseases.
登录
查看更多内容
DOI:
10.1002/ar.a.20015
发表时间:
2004-04-01
期刊:
ANATOMICAL RECORD PART A-DISCOVERIES IN MOLECULAR CELLULAR AND EVOLUTIONARY BIOLOGY
影响因子:
--
作者:
Annicotte, JS;Schoonjans, K;Auwerx, J
通讯作者:
Auwerx, J
影响因子:
14.5
作者:
Djelti, Fathia;Braudeau, Jerome;Cartier, Nathalie
通讯作者:
Cartier, Nathalie
影响因子:
6.1
作者:
Chen, Zhen;Liu, Jiao;Liu, Hongbing
通讯作者:
Liu, Hongbing
影响因子:
2.7
作者:
Iida, T;Kakiyama, G;Hofmann, AF
通讯作者:
Hofmann, AF
影响因子:
3.8
作者:
Feng, Mei-Tang;Wang, Ting;Mao, Shui-Chun
通讯作者:
Mao, Shui-Chun